NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models - Concepedia

Concepedia

Publication | Closed Access

NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models

385

Citations

24

References

2016

Year

Deborah H. Charych, Ute Hoch, John L. Langowski, Steve R. Lee, Murali K. Addepalli, Peter Kirk, Dawei Sheng, Xiaofeng Liu, Paul Sims, Laurie A. VanderVeen,

Clinical Cancer Research

Abstract

These data support further evaluation of NKTR-214 in humans for a variety of tumor types, adding to the repertoire of potent and potentially curative cancer immunotherapies.

References

	Year	Citations

Page 1